14.52
price up icon0.28%   0.04
after-market Dopo l'orario di chiusura: 14.54 0.02 +0.14%
loading

Keros Therapeutics Inc Azioni (KROS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
91.40%
18.17
211.19 3.042 0.388 0.037
Operating Expenses
2.06%
57.98
59.21 56.30 59.05 50.48
Benefits Costs and Expenses
3.06%
51.09
52.70 190.60 - -
Costs And Expenses
3.06%
51.09
52.70 32.52 59.05 50.48
Operating Income/Loss
126.19%
-39.82
152.04 -53.25 -58.66 -50.44
Nonoperating Income/Loss
6.89%
6.899
6.454 7.528 5.701 5.182
Income/Loss From Continuing Operations Before Tax
120.77%
-32.92
158.49 -187.56 0.388 -45.26
Income Tax Expense/Benefit
122.12%
-2.222
10.04 - - -
Income/Loss From Continuing Operations After Tax
120.68%
-30.70
148.45 -46.03 -52.96 -45.26
Net Income/Loss
120.68%
-30.70
148.45 -46.03 -52.96 -45.26
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.13%
40.61
40.56 0.9737 37.59 36.10
Diluted Average Shares
1.00%
40.61
41.02 0.9737 37.59 36.10
Basic Earnings Per Share
120.77%
-0.76
3.66 -1.12 -1.41 -1.25
Diluted Earnings Per Share
120.99%
-0.76
3.62 -1.12 -1.41 -1.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.92
price down icon 1.18%
$84.92
price down icon 2.30%
$26.29
price down icon 1.50%
$127.27
price down icon 0.41%
$112.55
price down icon 0.85%
biotechnology ONC
$319.32
price down icon 0.63%
Capitalizzazione:     |  Volume (24 ore):